Shanghai Yizhong Pharmaceutical Co Ltd (688091) — Cash Flow Reinvestment Rate
Shanghai Yizhong Pharmaceutical Co Ltd (688091) has a Cash Flow Reinvestment Rate of 1.44x as of September 2025, reinvesting CN¥30.36 Million (capex CN¥30.36 Million ) from operating cash flow of CN¥21.03 Million. Check 688091 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Shanghai Yizhong Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2022–2024)
Historical reinvestment intensity for Shanghai Yizhong Pharmaceutical Co Ltd across 3 annual periods. Explore how well can Shanghai Yizhong Pharmaceutical Co Ltd service its debt to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Shanghai Yizhong Pharmaceutical Co Ltd (2022–2024)
Year-by-year capital reinvestment analysis for Shanghai Yizhong Pharmaceutical Co Ltd. For live market cap and broader valuation context, see Shanghai Yizhong Pharmaceutical Co Ltd market cap and net worth.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 2.60x | CN¥102.42 Million | CN¥39.44 Million | CN¥80.04 Million | ▲ +367.8% |
| 2023 | 0.56x | CN¥48.06 Million | CN¥86.55 Million | CN¥8.78 Million | ▼ -88.6% |
| 2022 | 4.86x | CN¥538.15 Million | CN¥110.78 Million | CN¥35.88 Million | — |